
Nektar Therapeutics Inc. (NASDAQ:NKTR) stock traded higher on Thursday, with a session volume of 2.80 million versus the average volume of 1.96 million, according to data from Benzinga Pro.
Though there is no company-specific news to justify the movement. The investors are probably reacting as Sanofi SA (NASDAQ:SNY) stock tumbled after results from the global COAST 1 phase 3 study.